XGN Exagen

Exagen Says On Dec. 5, Co.'s Board Of Directors Approved Reduction In Force Of 42 Employees Intended To Conserve Co.'s Current Cash Resources

Exagen Says On Dec. 5, Co.'s Board Of Directors Approved Reduction In Force Of 42 Employees Intended To Conserve Co.'s Current Cash Resources

12-06 05:31

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersLifeStance Health Gr (NASDAQ:LFST) stock increased by 37.0% to $6.89 during Friday's pre-market session. The market value of their outstanding shares is at $2.5 billion. Apexigen (NASDAQ:APGN)

11-25 21:16

Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket

Gainers VEON Ltd. (NASDAQ:VEON) shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion).Cosmos Holdin

11-25 20:41

12 Health Care Stocks Moving In Thursday's Intraday Session

GainersVenus Concept (NASDAQ:VERO) stock increased by 42.8% to $0.31 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 15.0 million shares, making up 2199.8%

11-25 01:35

Cowen Lowers Exagen (NASDAQ:XGN) Price Target to $7.00

Exagen (NASDAQ:XGN – Get Rating) had its price objective decreased by Cowen to $7.00 in a report released on Thursday, Stock Target Advisor reports. Cowen's price objective would suggest a potential

11-19 15:31

Peering Into Exagen's Recent Short Interest

Exagen's (NASDAQ:XGN) short percent of float has fallen 34.48% since its last report. The company recently reported that it has 20 thousand shares sold short, which is 0.19% of all regular shares that

11-17 22:14

BTIG Adjusts Exagen's Price Target to $7 From $10, Keeps Buy Rating

08:09 AM EST, 11/17/2022 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co

11-17 21:19

Exagen Is Maintained at Buy by BTIG

Exagen Is Maintained at Buy by BTIG

11-17 20:11

Exagen Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 11/17/2022 105.88% BTIG $10 → $7 Maintains Buy 11/15/2022 105.88% Canaccord Genuity $8 → $7 Maintains Buy

11-17 20:06

Exagen Price Target Lowered to $7 From $10 at BTIG

11-17 19:30